share_log

B of A Securities Downgrades Outset Medical to Underperform, Lowers Price Target to $3

Benzinga ·  Oct 13, 2023 08:19

B of A Securities analyst Travis Steed downgrades Outset Medical (NASDAQ:OM) from Buy to Underperform and lowers the price target from $32 to $3.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment